Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

510 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply to M Yildiz et al.
Jensen MM, Færch K, Brock C, Quist JS. Jensen MM, et al. Among authors: brock c. J Nutr. 2024 Jun;154(6):1962-1963. doi: 10.1016/j.tjnut.2024.04.013. Epub 2024 Apr 13. J Nutr. 2024. PMID: 38615732 No abstract available.
Protocol for a single-centre, parallel-group, randomised, controlled, superiority trial on the effects of time-restricted eating on body weight, behaviour and metabolism in individuals at high risk of type 2 diabetes: the REStricted Eating Time (RESET) study.
Quist JS, Jensen MM, Clemmensen KKB, Pedersen H, Bjerre N, Størling J, Blond MB, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Færch K. Quist JS, et al. Among authors: brock c. BMJ Open. 2020 Aug 26;10(8):e037166. doi: 10.1136/bmjopen-2020-037166. BMJ Open. 2020. PMID: 32847912 Free PMC article.
Effects of 3 months of 10-h per-day time-restricted eating and 3 months of follow-up on bodyweight and cardiometabolic health in Danish individuals at high risk of type 2 diabetes: the RESET single-centre, parallel, superiority, open-label, randomised controlled trial.
Quist JS, Pedersen HE, Jensen MM, Clemmensen KKB, Bjerre N, Ekblond TS, Uldal S, Størling J, Wewer Albrechtsen NJ, Holst JJ, Torekov SS, Nyeland ME, Vistisen D, Jørgensen ME, Panda S, Brock C, Finlayson G, Blond MB, Færch K. Quist JS, et al. Among authors: brock c. Lancet Healthy Longev. 2024 May;5(5):e314-e325. doi: 10.1016/S2666-7568(24)00028-X. Epub 2024 Apr 5. Lancet Healthy Longev. 2024. PMID: 38588687 Free article. Clinical Trial.
Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes.
Okdahl T, Kufaishi H, Kornum D, Bertoli D, Krogh K, K Knop F, Hansen CS, Størling J, Rossing P, Brock B, Drewes AM, Brock C. Okdahl T, et al. Among authors: brock b, brock c. Sci Rep. 2024 Sep 9;14(1):21042. doi: 10.1038/s41598-024-72139-y. Sci Rep. 2024. PMID: 39251831 Free PMC article. Clinical Trial.
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial.
Kornum DS, Bertoli D, Kufaishi H, Wegeberg AM, Okdahl T, Mark EB, Høyer KL, Frøkjær JB, Brock B, Krogh K, Hansen CS, Knop FK, Brock C, Drewes AM. Kornum DS, et al. Among authors: brock b, brock c. Diabetologia. 2024 Jun;67(6):1122-1137. doi: 10.1007/s00125-024-06129-0. Epub 2024 Mar 28. Diabetologia. 2024. PMID: 38546822 Free PMC article. Clinical Trial.
510 results